AM
ABBV icon

AGF Management’s AbbVie ABBV Stock Holding History

AGF Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164M Sell
652,937
-1,295,183
-66% -$279M 0.64% 46
2026
Q1 		$424M Sell
1,948,120
-38,633
-2% -$8.57M 1.9% 6
2025
Q4 		$454M Buy
1,986,753
+979,601
+97% +$223M 1.97% 9
2025
Q3 		$233M Sell
1,007,152
-126,622
-11% -$25.8M 1.03% 23
2025
Q2 		$210M Buy
1,133,774
+366,342
+48% +$68.1M 0.95% 29
2025
Q1 		$161M Sell
767,432
-242,059
-24% -$47.1M 0.85% 29
2024
Q4 		$179M Buy
1,009,491
+242,337
+32% +$44.6M 0.89% 28
2024
Q3 		$151M Sell
767,154
-71,253
-8% -$13.3M 0.77% 34
2024
Q2 		$144M Buy
838,407
+30,848
+4% +$5.11M 0.8% 29
2024
Q1 		$147M Sell
807,559
-191,513
-19% -$33M 0.82% 30
2023
Q4 		$155M Buy
999,072
+86,890
+10% +$12.7M 0.91% 28
2023
Q3 		$136M Sell
912,182
-337,532
-27% -$49.6M 0.96% 23
2023
Q2 		$168M Buy
1,249,714
+306,011
+32% +$44.9M 1.22% 17
2023
Q1 		$150M Buy
943,703
+81,749
+9% +$12.5M 1.03% 19
2022
Q4 		$139M Buy
+861,954
New +$132M 1.01% 23

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AGF Management's ABBV Position: Q2 2026 in Review

AGF Management reduced its AbbVie (ABBV) stake by 66% in Q2 2026, selling an estimated $279M and leaving 652,937 shares worth $164M. The position accounts for 0.64% of the portfolio, ranked #46.

AGF Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $454M in Q4 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AGF Management held 652,937 shares of AbbVie worth $164M as of Q2 2026.
  • AGF Management sold 1,295,183 AbbVie shares in Q2 2026, an estimated $279M.
  • AbbVie made up 0.64% of AGF Management's portfolio in Q2 2026, its #46 holding.
  • AGF Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • AGF Management's AbbVie position peaked at $454M in Q4 2025.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.